Please use this identifier to cite or link to this item:
|Title:||Defensins: Antimicrobial peptides for therapeutic development|
|Authors:||Verma, C. |
|Source:||Verma, C.,Seebah, S.,Low, S.M.,Zhou, L.,Liu, S.P.,Li, J.,Beuerman, R.W. (2007-11). Defensins: Antimicrobial peptides for therapeutic development. Biotechnology Journal 2 (11) : 1353-1359. ScholarBank@NUS Repository. https://doi.org/10.1002/biot.200700148|
|Abstract:||A novel class of endogenous antimicrobial peptides called defensins has shown great versatility in their activity against a diverse range of microorganisms including bacteria, viruses and fungi. Their mode of action of bacterial cell lysis seems largely nonspecific and so promises to avert the development of resistance. These two features have made them an area of intense research activity and growing commercial interest. A successful multidisciplinary effort to investigate and develop novel defensins analogues has been established in Singapore that involves computer modeling, biochemistry, proteomics, chemical synthesis, molecular biology and clinical sciences. © 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.|
|Source Title:||Biotechnology Journal|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Mar 8, 2018
checked on Mar 10, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.